Table 1 Demographic and clinicopathological details of EOC patients (n = 53)
Patients | Characterstics | |
|---|---|---|
Primary EOC (n = 33) | Recurrent EOC (n = 18) | |
Age Median (Range) | 51.5 (34–74) | 50 (40–66) |
Stage | ||
I | 0 (0.0 %) | 0 (0.0%) |
II | 4 (12.1%) | 0 (0.0%) |
III | 21 (63.6 %) | 11 (61.6%) |
IV | 8 (24.2 % ) | 6 (33.3%) |
Unknown | 0 ( 0.0 %) | 1 (5.5%) |
Grade | ||
High | 28 (84.8%) | 15 (83.3%) |
Low | 2 (6.0%) | 1 (5.5%) |
Unknown | 3 (9.0%) | 2 (11.1%) |
Co-morbidity | ||
Yes | 17 (51.5%) | 6 (33.3%) |
No | 13 (39.3%) | 11 (61.1%) |
Unknown | 3 (0.9%) | 1 (5.5%) |
ASC+ Tumor | ||
Positive | 18 (54.5%) | 3 (16.6%) |
Negative | 11 (33.3%) | 14 (77.7%) |
Unknown | 4 (12.1%) | 1 (5.5%) |
Lymph node metastasis | ||
Positive | 18 (54.5%) | 10 (55.5%) |
Negative | 13 (39.3%) | 7 (38.8%) |
Unknown | 2 (6.0%) | 1 (5.5%) |
CA-125 Median (Range) | ||
Pretreatment | 503.75 (68.5–5111) | 241.7 (80–1320) |
Post treatment | 14.7 (3.9–293.7) | 43.35 (8.582–238.9) |